Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate): a prospective pharmacovigilance study.
about
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.Inhibitors in previously treated patients: a review of the literaturePatient data meta-analysis of Post-Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with rAHF-PFM.Epidemiology of inhibitor formation with recombinant factor VIII replacement therapy.Harmonization of clinical trial guidelines for assessing the risk of inhibitor development in hemophilia A treatment.Long-term efficacy and safety of prophylaxis with recombinant factor VIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) study.Current issues facing coagulationists--meeting report.Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
P2860
Q31098999-AFED0AEE-E02E-4183-A6B4-41168C8E6052Q34777714-4A9A2DEB-E745-40F4-9BB6-9A3C55A9B016Q35209354-5E9334F9-E46C-4BBE-9225-2DBA7C80F8BCQ36643868-2D4C07CD-E303-47D5-A968-02EC42345B0FQ37818493-52205ECE-A04E-4B1C-8CD0-ED3ECB1C30AAQ38888065-7D416B97-947F-45C9-A0BA-25E5DDC617A1Q45856057-FBAFC82E-6781-4020-B4B1-CE0B15001243Q49866575-26B22B87-20BF-46C9-ADF8-345F44A89CC3
P2860
Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate): a prospective pharmacovigilance study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Inhibitor development in patie ...... ctive pharmacovigilance study.
@en
Inhibitor development in patients receiving recombinant factor VIII
@nl
type
label
Inhibitor development in patie ...... ctive pharmacovigilance study.
@en
Inhibitor development in patients receiving recombinant factor VIII
@nl
prefLabel
Inhibitor development in patie ...... ctive pharmacovigilance study.
@en
Inhibitor development in patients receiving recombinant factor VIII
@nl
P2093
P2860
P1433
P1476
Inhibitor development in patie ...... ctive pharmacovigilance study.
@en
P2093
Ewenstein BM
Gomperts ED
O'Banion ME
P2860
P304
P356
10.1111/J.1365-2516.2004.00904.X
P577
2004-09-01T00:00:00Z